Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Addresses the unique challenges associated with ADC manufacturing, providing biopharmaceutical companies with a more efficient and safer solution.
September 10, 2024
By: Charlie Sternberg
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has launched its Mobius ADC Reactor, a single-use reactor specifically designed for the production of antibody drug conjugates (ADCs). ADCs, a rapidly growing class of therapeutic agents, offer targeted and selective killing of tumor cells while minimizing harm to healthy tissues. The Mobius ADC Reactor addresses the unique challenges associated with ADC manufacturing, providing biopharmaceutical companies with a more efficient and safer solution. By eliminating the need for labor-intensive cleaning procedures required by traditional stainless steel or glass reactors, the single-use technology offers faster turnaround times and reduced risk of cross-contamination. “We have been providing single-use solutions for flexible biopharmaceutical manufacturing for more than 15 years. Drawing on this extensive experience, we are now ready to accelerate the production of antibody-drug conjugates,” said Sebastian Arana, Head of Process Solutions, Life Science business of Merck KGaA, Darmstadt, Germany. “The launch of the Mobius ADC Reactor will support our customers to bring much-needed therapies to a global population.” The new reactor features innovative design elements, including the use of Ultimus Film technology for enhanced bag strength and durability. This technology, combined with optimized chemical compatibility and quality standards, ensures high product quality while minimizing waste. Merck KGaA’s comprehensive offering for ADC manufacturing includes a range of single-use systems, consumables, and services. The Mobius single-use systems for chromatography and tangential flow filtration (TFF) are particularly suited for closed-mode operations, while the Pellicon capsule provides essential consumables. Additionally, the company offers contract development and manufacturing organization (CDMO) services, as well as testing services for ADCs and high-potent active pharmaceutical ingredients (HPAPIs).
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !